Replies to post #104542 on NSAV Holding Inc (NSAV)

[Trademanager]

How much revenue is here possible for VSRI
in this cooperation between VSRI and ELI LILLY $ Co
if the market in China, treating diabetes and related diseases every year.China spends $50 billion treating diabetes and related diseases every year,
https://blogs.wsj.com/chinarealtime/2016/11/14/chinas-diabetes-problem-from-1-to-10-in-36-years/

How many Chinese people are there? China's 2017 population is 1.41 billion, !!! based on United Nations projections
http://worldpopulationreview.com/countries/china-population/

Shanghai based Vital Strategic Research Institute (VSRI), has signed an agreement with Eli Lilly and Company. Under the terms of the agreement, VSRI will provide Eli Lilly with an assessment of Cardio Vascular Disease (CVD) among newly diagnosed diabetes patients at increased risk of CVD in China

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137018469